Fundraising FoxINVVAX INC
2 known investors
Find your way into INVVAX INC
Sign up to find every way you can get introduced to INVVAX INC
- Your email: who you already know at INVVAX INC, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the INVVAX INC team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
InvVax is developing a universal influenza vaccine based on its own vaccine technology. The company focuses on biotechnology and vaccine research and commercialization.
Founders & leadership
Investors · 2
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2022 | $255.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does INVVAX INC do?
- InvVax is developing a universal influenza vaccine based on its own vaccine technology. The company focuses on biotechnology and vaccine research and commercialization.
- Who are INVVAX INC's investors?
- INVVAX INC's investors include Evolution VC Partners, Sand Hill Angels.